FACTS ASSERTED BY THE COMPLAINANT AND NOT CONTESTED BY THE RESPONDENT:
The European League Against Rheumatism (hereinafter “EULAR”) is the organisation which represents the patient, health professional and scientific societies of rheumatology of all the European nations. EULAR endeavours to stimulate, promote, and support the research, prevention, treatment and rehabilitation of rheumatic diseases. EULAR operates under the domain name <eular.org>.
EULAR is a truly pan-European organisation fostering a multitude of activities in areas of research, patient care, and education. To manage and promote its goals effectively, EULAR has set up a structure of committees and managerial bodies.
EULAR is set up of four types of institutional members: scientific societies, national organisations of people with arthritis/rheumatism and health professionals as well as corporate members.
With 45 scientific member societies, 36 PARE organisations and 25 health professionals associations, EULAR underscores the importance of combating rheumatic diseases not only by medical means, but also through a wider context of care for rheumatic patients and a thorough understanding of their social and other needs. 24 corporate members support EULAR financially with their membership fees.
Only one organisation from any one country is accepted as its representative.
The next EULAR Annual European Congress of Rheumatology will take place from 13–16 June 2018 in Amsterdam, Netherlands. The annual EULAR Congress continues to be a major event in the calendar of world rheumatology and Amsterdam 2018 will again provide an unique event for the exchange of scientific and clinical information tissue, locomotor and musculoskeletal systems. The official page regarding the Congress can be found in the following link www.congress.eular.org.
The Complainant has registered a number of domain names under generic Top-Level Domains ("gTLD") and country-code Top-Level Domains ("ccTLD") containing the term “EULAR”, for example, <eular.org> (created on April 02, 1996), <eular2018.com> (created on April 25, 1998). The Complainant uses these domain names to connect to a website through which it informs potential customers about its EULAR mark and its products and services.
The domain names <eular18.com> and <eular18.org> (hereinafter referred to as the “Domain Names”), which both were registered on 08.12.2017.
THE WEBSITES
1. The disputed domain name <eular18.com>
The Domain Name is pointing to pay-per-click (“PPC”) website where Internet visitors find related links to Complainant’s products and trademarks (see for example the advertisement placed at the Disputed Domain Name for “EULA”).
2. The disputed domain name <eular18.org>
Respondent is using the above Domain Name to attract internet users to its website where they are promoting the coming EULAR Annual European Congress of Rheumatology which will take place from 13–16 June 2018 in Amsterdam, Netherlands under the name of the Complainant without any authorization to do so. On their website, Respondent states “EULAR 2018 – European League Against Rheumatism”. Respondent has connected the Domain Name to a website which has the look and feel of an official EULAR domain name, however, the Complainant has not authorized in any way the Respondent to use any of its intellectual property rights as well as any other rights. Furthermore, the use of the word EULARS (i) in the Domain Name, (ii) in the e-mail address of info@eular18.com which is added as contact e-mail on the website and (iii) also in the text of the website multiple times in bold letters further create the impression that here is some official or authorized link with the Complainant for the purposes of promoting the coming Congress as well as to offer hotel accomodation & flight enquiries. In addition, the website requests sensitive information (e-mail address, name, phone) from internet users for purposes of contacting the Respondent.
Respondent's use of the Domain Name creates an overall impression that they are the Complainant.
|